Magnetic resonance imaging (MRI) data has been extensively applied in diagnosing and predicting Alzheimer’s disease (AD). However, there has been a notable oversight in addressing individual heterogen
BackgroundNumerous efforts have been made to identify biomarkers for predicting the progression of dementia in patients with mild cognitive impairment (MCI), and recently, a comprehensive visual ratin
Wilcoxon rank-sum test with false discovery rate (FDR) multiple correction was performed to compare single protein expression level between MCI converters and non-converters. UniProt ID, beta-coeffici
Predictive models in biomedicine need to ensure equitable and reliable outcomes for the populations they are applied to. However, biases in AI models for medical predictions can lead to unfair treatme